CA
ADMA icon

Commerzbank Aktiengesellschaft’s ADMA Biologics ADMA Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-39,086
Closed -$327K – 1146
2015
Q3 		$327K Buy
+39,086
New +$361K ﹤0.01% 924

Other funds holding ADMA

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BCM
Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Commerzbank Aktiengesellschaft's ADMA Position: Q4 2015 in Review

Commerzbank Aktiengesellschaft sold out of ADMA Biologics (ADMA) in Q4 2015, closing a stake of 39,086 shares — an estimated $327K sold.

Commerzbank Aktiengesellschaft first reported a position in ADMA in Q3 2015 and held it in 1 quarter. The position peaked at $327K in Q3 2015. 26 funds tracked by Wall St. Rank hold ADMA as of Q4 2015.

  • Commerzbank Aktiengesellschaft reported no remaining ADMA Biologics position as of Q4 2015 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 39,086 ADMA Biologics shares in Q4 2015, an estimated $327K.
  • Commerzbank Aktiengesellschaft first reported a position in ADMA Biologics in Q3 2015 and held it in 1 quarter.
  • Commerzbank Aktiengesellschaft's ADMA Biologics position peaked at $327K in Q3 2015.
  • 26 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2015.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q4 2015, filed 5 Feb 2016.